dsco Discovery Laboratories Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : dsco Discovery Laboratories

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Michael Young who wrote (284)	3/6/2012 5:17:52 PM
From: Arthur Radley	of 318

Michael, The initial market for premature babies is fairly small--around 90,000 -100,000 yearly here in the US. However, when you factor in the full application for their technology--adults and other lung ailments that can be enhanced by their delivery system........we are talking big money. I think I remember that at one time DSCO projected a market of around $1B. Also, (IMO) this drug will not face the normal reluctance that doctors have in switching to another drug from what they have been utilizing. Short term--we are probably looking at a stock offering to fund the launch. But also(IMO) they will be a prime candidate for a take out by one of the major pharmas. Again, without looking, I think they had a MC of under $100 million, so with a $1 Billion market potential............I ain't selling my shares until the dust settles.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next